Cubist Pharmaceuticals - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Cubist Pharmaceuticals M&A Summary

Cubist Pharmaceuticals has acquired 5 companies of its own.

Cubist Pharmaceuticals’ largest acquisition to date was in 2013, when it acquired Optimer Pharmaceuticals for $801M. Cubist Pharmaceuticals has acquired in 4 different US states. The Company’s most targeted sectors include life science (100%).

Cubist Pharmaceuticals Ownership

Who owns Cubist Pharmaceuticals?

Cubist Pharmaceuticals is owned by Merck. It was acquired on January 22, 2015.

Cubist Pharmaceuticals Business Overview

Where is Cubist Pharmaceuticals headquartered?

Cubist Pharmaceuticals is headquartered in Lexington, Massachusetts.

How many employees does Cubist Pharmaceuticals have?

Cubist Pharmaceuticals has 900 employees.

What sector is Cubist Pharmaceuticals in?

Cubist Pharmaceuticals is a life science company.

When was Cubist Pharmaceuticals founded?

Cubist Pharmaceuticals was founded in 1992.

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity5
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 3

Cubist Pharmaceuticals, Inc.

65 Hayden Avenue,
Lexington, Massachusetts 02421
United States,
(781) 860-8660
www.cubist.com

Cubist Pharmaceuticals, Inc. is a bio-pharmaceutical company focused on the research, commercial­ization and creation of pharmaceutical products that address unmet medical needs in the acute care environment.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 5 - - - - - 5
vol $2.0B $2.0B
Sell (0.0/yr) # - - - - - - 0
  5

Most Recent M&A

Company Date Value Type
Optimer Pharmaceuticals, Inc. 2013-10-24 801M USD Add-on Acquisition
Jersey City, New Jersey · www.optimerpharma.com
Trius Therapeutics, Inc. 2013-07-30 707M USD Add-on Acquisition
San Diego, California · www.triusrx.com
Adolor Corp. 2011-12-12 453M USD Add-on Acquisition
Exton, Pennsylvania · www.adolor.com
Calixa Therapeutics, Inc. 2009-12-14 - Add-on Acquisition
San Diego, California · www.calixainc.com
Illumigen Biosciences, Inc. 2007-12-26 - Add-on Acquisition
Seattle, Washington
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 5 (100%) 2.0B (100%) - -
Total 5 $2.0B - -

By Geo

State/Country Buy Value Sell Value
United States 5 2.0B - -
  California 2 707M - -
  Washington 1 - - -
  Pennsylvania 1 453M - -
  New Jersey 1 801M - -
Total 5 $2.0B - -

Top M&A Advisors

Financial Deals
Morgan Stanley
2
Barclays Investment Bank
1
Legal Deals
Ropes & Gray
3

Deal Values

buy # Total
$100M to $1B 3 $2.0B
TOTAL $2.0B
Largest Optimer Pharmaceuticals, Inc.
$801M (2013-10-24)

 Subscribe to unlock this and 207,600
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.